Who Paid My Doc
Brineura
Drug Cln 2
NDC 68135-811-02
General payments
$47,250
Research payments
$382,403
Through program year 2025, $47,250 in general payments and $382,403 in research payments were reported against Brineura (Cln 2).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $11,924 | 147 |
| 2025 | Research | $103,853 | 4 |
| 2024 | General | $28,345 | 190 |
| 2024 | Research | $278,549 | 4 |
| 2023 | General | $3,832 | 1 |
| 2022 | General | $3,149 | 29 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
367 general · 8 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.